JPS5721246B2 - - Google Patents

Info

Publication number
JPS5721246B2
JPS5721246B2 JP8549379A JP8549379A JPS5721246B2 JP S5721246 B2 JPS5721246 B2 JP S5721246B2 JP 8549379 A JP8549379 A JP 8549379A JP 8549379 A JP8549379 A JP 8549379A JP S5721246 B2 JPS5721246 B2 JP S5721246B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8549379A
Other languages
Japanese (ja)
Other versions
JPS5610119A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8549379A priority Critical patent/JPS5610119A/ja
Priority to GB8106701A priority patent/GB2065473B/en
Priority to PCT/US1980/000834 priority patent/WO1981000050A1/en
Priority to DE19803049690 priority patent/DE3049690A1/de
Publication of JPS5610119A publication Critical patent/JPS5610119A/ja
Publication of JPS5721246B2 publication Critical patent/JPS5721246B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP8549379A 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine Granted JPS5610119A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP8549379A JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine
GB8106701A GB2065473B (en) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine
PCT/US1980/000834 WO1981000050A1 (en) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine
DE19803049690 DE3049690A1 (de) 1979-07-05 1980-07-03 Process for producing hepatitis b vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8549379A JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine

Publications (2)

Publication Number Publication Date
JPS5610119A JPS5610119A (en) 1981-02-02
JPS5721246B2 true JPS5721246B2 (enExample) 1982-05-06

Family

ID=13860454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8549379A Granted JPS5610119A (en) 1979-07-05 1979-07-05 Manufacture of b type hepatitis infection preventive vaccine

Country Status (3)

Country Link
JP (1) JPS5610119A (enExample)
GB (1) GB2065473B (enExample)
WO (1) WO1981000050A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
FR2561256B1 (fr) * 1984-03-16 1987-01-02 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
NL8401066A (nl) * 1984-04-04 1985-11-01 Stichting Centraal Lab Werkwijze ter bereiding van preparaten, die de humorale en cellulaire immuunreaktiviteit vergroten.
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
EP0384058A1 (en) * 1989-02-09 1990-08-29 Development Center For Biotechnology Isolation of hepatitis B surface antigen from transformed yeast cells
AU657168B2 (en) * 1991-09-18 1995-03-02 Amgen, Inc. Hepatitis B vaccine with bile salt adjuvant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (enExample) * 1962-01-03
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
FR2336141A1 (fr) * 1975-12-23 1977-07-22 Trepo Christian Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Also Published As

Publication number Publication date
WO1981000050A1 (en) 1981-01-22
JPS5610119A (en) 1981-02-02
GB2065473B (en) 1984-02-29
GB2065473A (en) 1981-07-01

Similar Documents

Publication Publication Date Title
BR8002583A (enExample)
BR8006808A (enExample)
FR2449000B1 (enExample)
AT364253B (enExample)
AU78569S (enExample)
AU79558S (enExample)
AU78386S (enExample)
AU78390S (enExample)
AU78391S (enExample)
AU78271S (enExample)
AU78270S (enExample)
AU79200S (enExample)
AU79557S (enExample)
AU78385S (enExample)
AU79559S (enExample)
AU79826S (enExample)
AU79918S (enExample)
AU79950S (enExample)
AU80228S (enExample)
AU77763S (enExample)
BR5901094U (enExample)
AU78389S (enExample)
AU77669S (enExample)
BG28434A1 (enExample)
BG28730A1 (enExample)